Market Cap 230.25B
Revenue (ttm) 168.30B
Net Income (ttm) 14.31B
EPS (ttm) N/A
PE Ratio 13.04
Forward PE 11.94
Profit Margin 8.50%
Debt to Equity Ratio 1.56
Volume 10,160,200
Avg Vol 13,009,548
Day's Range N/A - N/A
Shares Out 1.71B
Stochastic %K 66%
Beta 1.12
Analysts Strong Sell
Price Target $151.56

Company Profile

Citigroup Inc., a diversified financial service holding company, provides various financial products and services to consumers, corporations, governments, and institutions. It operates through five segments: Services, Markets, Banking, U.S. Personal Banking, and Wealth. The Services segment includes treasury and trade solutions, which provides cash management, trade, and working capital solutions to multinational corporations, financial institutions, and public sector organizations; and securiti...

Industry: Banks - Diversified
Sector: Financial Services
Phone: 212 559 1000
Address:
388 Greenwich Street, New York, United States
In_N__Out
In_N__Out Aug. 8 at 4:52 PM
$BAC $GS $C $JPM $USB dicey. No jobs and high unemployment results in banks inflow drops.
0 · Reply
Rfm101
Rfm101 Aug. 7 at 1:05 PM
$C quilled chicken with cheese
0 · Reply
mrnobody617
mrnobody617 Aug. 7 at 12:10 PM
$C gives $APP a $650 https://www.tipranks.com/news/the-fly/applovin-price-target-lowered-to-650-from-710-at-citi-thefly-news
0 · Reply
Chickenstick1
Chickenstick1 Aug. 6 at 7:43 PM
$BAC Selling shares and adding to $C and $GS.
0 · Reply
Chickenstick1
Chickenstick1 Aug. 6 at 6:45 PM
$C $GS Picking up a few shares here.
0 · Reply
Rfm101
Rfm101 Aug. 6 at 1:11 PM
$C dice I
0 · Reply
Rfm101
Rfm101 Aug. 6 at 1:11 PM
$C rolling dice!!
0 · Reply
topstockalerts
topstockalerts Aug. 6 at 1:52 AM
Investment banks expect Petrobras to report a strong Q2 2026, with cash generation roughly doubling year over year on higher oil and gas production, stronger Brent prices, and improved fuel pricing. Bank of America forecasts adjusted EBITDA of $18.4 billion, while the Bloomberg consensus calls for R$91.3 billion ($18 billion) in adjusted EBITDA, R$45.1 billion ($9 billion) in net income, and R$161.6 billion ($32 billion) in revenue. Citi expects similar EBITDA and estimates $3.5 billion in dividends. Despite the strong operating outlook, analysts remain cautious on the stock. Citi maintained a Neutral rating and cut its price target, citing limited upside for oil prices, stable fuel margins through 2026, and the extension of Brazil's oil export tax, which could weigh on future earnings. While higher refining margins provide some support, banks believe much of the near-term operational improvement is already reflected in the share price. $PBR $BAC $C
0 · Reply
topstockalerts
topstockalerts Aug. 6 at 12:16 AM
Attovia Therapeutics shares jumped 24% in their Nasdaq debut after the clinical-stage biopharmaceutical company raised $289 million in its IPO. The stock opened at $21 per share, above its $17 IPO price, giving the company an initial market value of nearly $904 million. The company sold 17 million shares at $17 each and granted underwriters a 30-day option to purchase up to 2.55 million additional shares at the offering price. The transaction is expected to close on August 6, subject to customary closing conditions. Attovia is developing novel therapeutics using a technology platform and intellectual property licensed from Alamar Biosciences, which spun off the company in 2023 and remains an investor. Alamar completed its own IPO earlier this year, raising about $220 million, and its shares have gained nearly 70% since listing. The IPO was led by Morgan Stanley, Leerink Partners, Citigroup, and RBC Capital Markets as joint book-running managers $NDAQ $MS $C
0 · Reply
Stockprofiler
Stockprofiler Aug. 5 at 8:07 PM
$BURU Expecting #Shortsqueeze $C Offer great loans
0 · Reply
Latest News on C
Citi price target lowered to $142 from $150 at UBS

2026-08-03T11:41:47.000Z - 5 days ago

Citi price target lowered to $142 from $150 at UBS

MXC


Citi Teams With Infor to Debut Invoice Processing Tool

Jul 28, 2026, 3:48 PM EDT - 11 days ago

Citi Teams With Infor to Debut Invoice Processing Tool


Citi launches Citi Consolidate invoice processing solution

2026-07-28T13:10:42.000Z - 11 days ago

Citi launches Citi Consolidate invoice processing solution

MXC


Citigroup Declares Common Stock Dividend

Jul 21, 2026, 5:32 PM EDT - 18 days ago

Citigroup Declares Common Stock Dividend


Citigroup Announces Full Redemption of Series T Preferred Stock

Jul 16, 2026, 4:15 PM EDT - 23 days ago

Citigroup Announces Full Redemption of Series T Preferred Stock


Banks Are on a Goldilocks Run. Don't Assume It Will Last.

Jul 15, 2026, 5:30 AM EDT - 24 days ago

Banks Are on a Goldilocks Run. Don't Assume It Will Last.

BAC GS JPM MS WFC


Big Banks' Profits Surge in Red-Hot Quarter

Jul 14, 2026, 4:08 PM EDT - 25 days ago

Big Banks' Profits Surge in Red-Hot Quarter

BAC GS JPM WFC


Citigroup Earnings Call Transcript: Q2 2026

Jul 14, 2026, 11:00 AM EDT - 25 days ago

Citigroup Earnings Call Transcript: Q2 2026


Citigroup Earnings release: Q2 2026

Jul 14, 2026, 11:00 AM EDT - 25 days ago

Citigroup Earnings release: Q2 2026


Citigroup Slides: Q2 2026

Jul 14, 2026, 11:00 AM EDT - 25 days ago

Citigroup Slides: Q2 2026


Citigroup Quarterly report: Q2 2026

Jul 14, 2026, 11:00 AM EDT - 25 days ago

Citigroup Quarterly report: Q2 2026


Citi Stock Traders Post Record Revenue for Quarter

Jul 14, 2026, 9:11 AM EDT - 25 days ago

Citi Stock Traders Post Record Revenue for Quarter


Wells Fargo's Mike Mayo: Citi My Top Pick of Big Banks

Jul 14, 2026, 8:33 AM EDT - 25 days ago

Wells Fargo's Mike Mayo: Citi My Top Pick of Big Banks


Citigroup Reports Second Quarter 2026 Results

Jul 14, 2026, 8:01 AM EDT - 25 days ago

Citigroup Reports Second Quarter 2026 Results


What to Expect From Wall Street Banks Earnings

Jul 14, 2026, 1:17 AM EDT - 25 days ago

What to Expect From Wall Street Banks Earnings

BAC GS JPM MS WFC


Bank earnings on deck: Here's what to expect

Jul 13, 2026, 11:25 AM EDT - 26 days ago

Bank earnings on deck: Here's what to expect

BAC GS JPM KRE MS WFC XLF


The Big 3: INTC, C, BFLY

Jun 22, 2026, 1:00 PM EDT - 6 weeks ago

The Big 3: INTC, C, BFLY

BFLY INTC


In_N__Out
In_N__Out Aug. 8 at 4:52 PM
$BAC $GS $C $JPM $USB dicey. No jobs and high unemployment results in banks inflow drops.
0 · Reply
Rfm101
Rfm101 Aug. 7 at 1:05 PM
$C quilled chicken with cheese
0 · Reply
mrnobody617
mrnobody617 Aug. 7 at 12:10 PM
$C gives $APP a $650 https://www.tipranks.com/news/the-fly/applovin-price-target-lowered-to-650-from-710-at-citi-thefly-news
0 · Reply
Chickenstick1
Chickenstick1 Aug. 6 at 7:43 PM
$BAC Selling shares and adding to $C and $GS.
0 · Reply
Chickenstick1
Chickenstick1 Aug. 6 at 6:45 PM
$C $GS Picking up a few shares here.
0 · Reply
Rfm101
Rfm101 Aug. 6 at 1:11 PM
$C dice I
0 · Reply
Rfm101
Rfm101 Aug. 6 at 1:11 PM
$C rolling dice!!
0 · Reply
topstockalerts
topstockalerts Aug. 6 at 1:52 AM
Investment banks expect Petrobras to report a strong Q2 2026, with cash generation roughly doubling year over year on higher oil and gas production, stronger Brent prices, and improved fuel pricing. Bank of America forecasts adjusted EBITDA of $18.4 billion, while the Bloomberg consensus calls for R$91.3 billion ($18 billion) in adjusted EBITDA, R$45.1 billion ($9 billion) in net income, and R$161.6 billion ($32 billion) in revenue. Citi expects similar EBITDA and estimates $3.5 billion in dividends. Despite the strong operating outlook, analysts remain cautious on the stock. Citi maintained a Neutral rating and cut its price target, citing limited upside for oil prices, stable fuel margins through 2026, and the extension of Brazil's oil export tax, which could weigh on future earnings. While higher refining margins provide some support, banks believe much of the near-term operational improvement is already reflected in the share price. $PBR $BAC $C
0 · Reply
topstockalerts
topstockalerts Aug. 6 at 12:16 AM
Attovia Therapeutics shares jumped 24% in their Nasdaq debut after the clinical-stage biopharmaceutical company raised $289 million in its IPO. The stock opened at $21 per share, above its $17 IPO price, giving the company an initial market value of nearly $904 million. The company sold 17 million shares at $17 each and granted underwriters a 30-day option to purchase up to 2.55 million additional shares at the offering price. The transaction is expected to close on August 6, subject to customary closing conditions. Attovia is developing novel therapeutics using a technology platform and intellectual property licensed from Alamar Biosciences, which spun off the company in 2023 and remains an investor. Alamar completed its own IPO earlier this year, raising about $220 million, and its shares have gained nearly 70% since listing. The IPO was led by Morgan Stanley, Leerink Partners, Citigroup, and RBC Capital Markets as joint book-running managers $NDAQ $MS $C
0 · Reply
Stockprofiler
Stockprofiler Aug. 5 at 8:07 PM
$BURU Expecting #Shortsqueeze $C Offer great loans
0 · Reply
totally_possible
totally_possible Aug. 5 at 7:35 PM
$DOCN 190 PT from $C
0 · Reply
Reanimated666
Reanimated666 Aug. 5 at 5:25 PM
$C Doubled position here
0 · Reply
Twinity
Twinity Aug. 5 at 3:26 PM
$VG wth,, IS $V $C $UBS stock going down with the forex rates on daily???/ how is a major US #lng exporter trading inline with crude or TTF rates?? How about 2x below its IPO price or Double revenues growth that about to double one more time with CP2 project going online!! this stock doesn't need the war drama nor is a commodity index.. despite the f up's
0 · Reply
Rfm101
Rfm101 Aug. 5 at 2:36 PM
$C uptown!&!
0 · Reply
John_Wick1234
John_Wick1234 Aug. 5 at 11:16 AM
$C Open Equals Low with Volume.
0 · Reply
JackDarwin
JackDarwin Aug. 5 at 11:13 AM
$C Bullish Gap up with open equals low.
0 · Reply
topstockalerts
topstockalerts Aug. 5 at 1:54 AM
Attovia Therapeutics, a clinical-stage biopharmaceutical company, priced its upsized IPO at $17 per share, offering 17 million common shares to raise approximately $289 million in gross proceeds before underwriting discounts, commissions, and other expenses. The company also granted underwriters a 30-day option to purchase up to 2.55 million additional shares, which could further increase the size of the offering if fully exercised. The stock is expected to begin trading on the Nasdaq Global Market on Aug. 5 under the ticker ATTO, with the offering scheduled to close on Aug. 6, subject to customary closing conditions. Morgan Stanley, Leerink Partners, Citigroup, and RBC Capital Markets are acting as joint book-running managers, while LifeSci Capital is serving as passive bookrunner. Attovia is developing antibody-based therapies for immune-mediated diseases. Its lead clinical candidate, ATTO-1310, is an anti-IL-31 therapy for chronic pruritic diseases $C
0 · Reply
FlipFlop12
FlipFlop12 Aug. 4 at 7:43 PM
$XPEV does someone understand why Xpeng does not explode above $50 when $JEF $BAC $C all have price targets for Xpeng which are above $25? Why is it at only $12 although Xpengs are selling like hot chocolate in Europe and especially in germany. So hot https://www.xpeng.com/de
1 · Reply
zoey1970
zoey1970 Aug. 4 at 5:53 PM
0 · Reply
Reanimated666
Reanimated666 Aug. 4 at 4:23 PM
0 · Reply
ortega1963
ortega1963 Aug. 4 at 3:21 PM
$C Long 137
0 · Reply
Rfm101
Rfm101 Aug. 4 at 12:16 PM
$C upgraded!!
0 · Reply